Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 362 (LINC00362) is a human long intergenic non-coding RNA (lincRNA). LINC00362 does not encode a protein but is classified as a lincRNA because it is transcribed from genomic regions that do not overlap protein-coding genes. LincRNAs are generally over 200 nucleotides in length and have been implicated in a variety of regulatory functions in the cell. They may regulate gene expression at the transcriptional or post-transcriptional level, often acting through interaction with chromatin modifiers, transcription factors, or other proteins[5][7][9]. While some lincRNAs have well-characterized roles in cancer, gene regulation, or epigenetics, the specific biological function, clinical relevance, or disease association of LINC00362 is not currently well-established. There is no evidence that it acts as a receptor, enzyme, transporter, or classical therapeutic target, nor that it has known drug interactions or proven biomarker status[1][3][5]. Thus, it is primarily considered a part of the non-coding transcriptome with possible but as yet uncharacterized regulatory roles[5][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 362 (LINC00362).